Adam Schechter, CEO of LabCorp announced in LinkedIn that their clinical development business will become Fortrea. He wrote “Last July, we announced our intention to spin our Clinical Development business from Labcorp to create two independent, publicly traded companies, each poised for strong, sustainable growth. I am excited to share that this new business will become Fortrea.
The team at Fortrea will work to solve complexities within clinical trials to help our customers make life-changing innovation possible. The name represents a belief that the exceptional is possible with the right partner. With decades of know-how combined with the operational nimbleness needed today, Fortrea intends to drive innovation and help customers advance next-generation therapies for patients worldwide. ”
Learn more about Fortrea: www.fortrea.com
/cloudfront-us-east-2.images.arcpublishing.com/reuters/45MIO7JJTFLQDM2QDIHOJZI6BM.jpg)
